Cargando…
When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy
Recent significant strides of natural compounds in immunomodulation have highlighted their great potential against cancer. Despite many attempts being made for cancer immunotherapy, the biomedical application of natural compounds encounters a bottleneck because of their unclear mechanisms, low solub...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412684/ https://www.ncbi.nlm.nih.gov/pubmed/36015215 http://dx.doi.org/10.3390/pharmaceutics14081589 |
_version_ | 1784775554815229952 |
---|---|
author | Yu, Linna Jin, Yi Song, Mingjie Zhao, Yu Zhang, Huaqing |
author_facet | Yu, Linna Jin, Yi Song, Mingjie Zhao, Yu Zhang, Huaqing |
author_sort | Yu, Linna |
collection | PubMed |
description | Recent significant strides of natural compounds in immunomodulation have highlighted their great potential against cancer. Despite many attempts being made for cancer immunotherapy, the biomedical application of natural compounds encounters a bottleneck because of their unclear mechanisms, low solubility and bioavailability, and limited efficacy. Herein, we summarize the immune regulatory mechanisms of different natural compounds at each step of the cancer-immunity cycle and highlight their anti-tumor potential and current limitations. We then propose and present various drug delivery strategies based on nanotechnology, including traditional nanoparticles (NPs)-based delivery strategies (lipid-based NPs, micelles, and polysaccharide/peptide/protein-based NPs) and novel delivery strategies (cell-derived NPs and carrier-free NPs), thus providing solutions to break through existing bottlenecks. Furthermore, representative applications of nature-inspired nanomedicines are also emphasized in detail with the advantages and disadvantages discussed. Finally, the challenges and prospects of natural compounds for cancer immunotherapy are provided, hopefully, to facilitate their far-reaching development toward clinical translation. |
format | Online Article Text |
id | pubmed-9412684 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-94126842022-08-27 When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy Yu, Linna Jin, Yi Song, Mingjie Zhao, Yu Zhang, Huaqing Pharmaceutics Review Recent significant strides of natural compounds in immunomodulation have highlighted their great potential against cancer. Despite many attempts being made for cancer immunotherapy, the biomedical application of natural compounds encounters a bottleneck because of their unclear mechanisms, low solubility and bioavailability, and limited efficacy. Herein, we summarize the immune regulatory mechanisms of different natural compounds at each step of the cancer-immunity cycle and highlight their anti-tumor potential and current limitations. We then propose and present various drug delivery strategies based on nanotechnology, including traditional nanoparticles (NPs)-based delivery strategies (lipid-based NPs, micelles, and polysaccharide/peptide/protein-based NPs) and novel delivery strategies (cell-derived NPs and carrier-free NPs), thus providing solutions to break through existing bottlenecks. Furthermore, representative applications of nature-inspired nanomedicines are also emphasized in detail with the advantages and disadvantages discussed. Finally, the challenges and prospects of natural compounds for cancer immunotherapy are provided, hopefully, to facilitate their far-reaching development toward clinical translation. MDPI 2022-07-30 /pmc/articles/PMC9412684/ /pubmed/36015215 http://dx.doi.org/10.3390/pharmaceutics14081589 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Yu, Linna Jin, Yi Song, Mingjie Zhao, Yu Zhang, Huaqing When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
title | When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
title_full | When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
title_fullStr | When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
title_full_unstemmed | When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
title_short | When Natural Compounds Meet Nanotechnology: Nature-Inspired Nanomedicines for Cancer Immunotherapy |
title_sort | when natural compounds meet nanotechnology: nature-inspired nanomedicines for cancer immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9412684/ https://www.ncbi.nlm.nih.gov/pubmed/36015215 http://dx.doi.org/10.3390/pharmaceutics14081589 |
work_keys_str_mv | AT yulinna whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy AT jinyi whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy AT songmingjie whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy AT zhaoyu whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy AT zhanghuaqing whennaturalcompoundsmeetnanotechnologynatureinspirednanomedicinesforcancerimmunotherapy |